 - Use of oral contraceptives; androgens; luteinizing-hormone-releasing-hormone LHRH analogs, prolactin inhibitors, antiandrogens, tamoxifen, raloxifen, or aromatase inhibitors; women who discontinue these drugs at least 3 months prior to study enrollment will be eligible 